Enteric fever, commonly known as typhoid fever, is a life-threatening systemic illness caused primarily by Salmonella Typhi and Paratyphi. Although the global burden of the disease has decreased, it remains a significant public health issue in many low and middle-income countries. This article aims to provide an in-depth analysis of the effective strategies for the management of enteric fever in clinical practice.
Early diagnosis is crucial in the management of enteric fever. It is primarily based on clinical suspicion, history of exposure, and laboratory confirmation. Widal test, blood culture, and bone marrow culture are commonly used diagnostic methods. However, these tests have their limitations, and hence, newer molecular diagnostic techniques like PCR are being increasingly used.
Antibiotic therapy forms the cornerstone of enteric fever management. The choice of antibiotics is often guided by local susceptibility patterns. Fluoroquinolones, cephalosporins, and azithromycin are commonly used. However, the emergence of multi-drug resistant strains poses a significant challenge, necessitating regular surveillance and judicious use of antibiotics.
Vaccination is a highly effective preventive strategy. Currently, two vaccines, Vi polysaccharide vaccine and Ty21a, are recommended by the World Health Organization. However, their use is limited by factors such as cost, availability, and the need for multiple doses. Efforts are ongoing to develop a single-dose, affordable, and long-lasting vaccine.
Public health measures like provision of safe drinking water, proper sanitation, and health education play a vital role in preventing enteric fever. These measures not only reduce the incidence of the disease but also curb the spread of antibiotic-resistant strains.
In conclusion, the management of enteric fever requires a multi-pronged approach, including early diagnosis, appropriate antibiotic therapy, vaccination, and public health measures. Ongoing research and development in the field of diagnostics and vaccines, along with strengthening of public health infrastructure, are the keys to controlling this disease.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation